Drug intelligence / Profile preview

acyl-ghrelin

Development stage
Phase 1
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous, Intranasal
01

Overview

Acyl-ghrelin is the active, acylated form of the endogenous peptide hormone ghrelin. It is produced primarily in the stomach and requires an n-octanoylation at serine 3 for biological activity. Acyl-ghrelin acts as a potent agonist of the growth hormone secretagogue receptor 1a (GHSR1a), stimulating appetite and food intake via hypothalamic pathways. Beyond its orexigenic effects, synthetic human acyl-ghrelin has demonstrated cardiovascular benefits in clinical studies—most notably improving cardiac output and stroke volume in patients with heart failure with reduced ejection fraction (HFrEF) without causing hypotension or arrhythmias. Mechanistically, it increases myocardial contractility independently of calcium mobilization by reducing troponin I phosphorylation[1][5]. Acyl-ghrelin has also been studied for its roles in metabolic regulation and neuropsychiatric processes.

Other names
acylated ghrelinoctanoyl ghrelin
02

Targets

GHSR (Growth hormone secretagogue receptor)

Beyond the preview

Go deeper on acyl-ghrelin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acyl-ghrelin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call